Informed consent is an
ethical concept—that all patients should understand
and agree to the potential consequences of their care—that
has become codified in the law and in daily practice at
every medical institution. One of the earliest legal precedents
in this area was established in 1914 when a physician removed
a tumor from the abdomen of a patient who had consented
to only a diagnostic procedure (Schloendorff vs. Society
of New York Hospital). The judge in this case ruled that
the physician was liable for battery because he violated
an “individual’s fundamental right to decide
what is being done with his or her body.” [Edwards
1998, Wescott 2005] The first case actually defining the
elements of informed consent occurred in the late 1950s
and involved a question of potential negligence and whether
a patient was given sufficient information to make a decision.
The case law and rules pertaining to informed consent have
changed over the years and all 50 states now have legislation
that requires some level of informed consent. [Pape T 1997]
Although the details of these laws vary from state to state,
the bottom line is that failure to obtain informed consent
renders any U.S. physician liable for negligence or battery
and constitutes medical malpractice. [Pizzi 2001] Exceptions
are made for emergencies or legally adjudicated mental incompetency
or physical incapacity. Several of the common elements required
for full disclosure have been summarized by the American
Medical Association (Table 1) and other
groups representing specialists or quality assurance organizations.
[AMA 1998] For example, federal regulations spell out the
minimum requirements for a properly executed informed consent
form (Table 2) and state that this form
must be in the patient’s chart before surgery. [CFR
Title 42] These regulations also stipulate that the information
must be given in a language or means of communication that
the patient understands. The U.S. government requires interpretation
and translation services for individuals with limited English
proficiency at institutions that receive federal funding;
these regulations also state that informed consent forms
must be translated into languages spoken by 5% or 1,000
of a provider’s patients—whichever is less.
[Executive Order 13166]
[Table 1] The Basic Features of Everyday Informed Consent
The physician (not a delegated representative) should disclose and discuss:
The diagnosis, if known
The nature and purpose of a proposed treatment
or procedure
The risks and benefits of proposed treatment or procedures
Alternatives (regardless of costs or extent covered by insurance)
The risks and benefits of alternatives
The risks and benefits of not receiving treatments or undergoing procedures
Source: AMA 1998
[Table 2] What’s Needed on the
Informed Consent Form
Name and signature of the patient, or if appropriate, legal representative
Name of the hospital
Name of procedure(s)
Name of all practitioners performing the procedure and individual significant
tasks if more than one practitioner
Risks
Benefits
Alternative procedures and treatments and their risks
Date and time consent is obtained
Statement that procedure was explained to patient or guardian
Signature of person witnessing the consent
Name and signature of person who explained the procedure to the patient or guardian
Which procedures require informed consent? Unfortunately there is no continually updated national list describing exactly when informed consent is required. Again, it varies from state to state and is also influenced by clinician or hospital interpretation of recommendations from professional and specialty groups.
For example:
Pennsylvania state law specifically requires that consent
be obtained for blood transfusions, chemotherapy, and
methadone use as part of a narcotics treatment program.
[PA Law Code]
Many states have developed specific laws governing breast
cancer diagnosis and treatment. [ACS 2007]
The American College of Obstetrics and Gynecology has
developed detailed guidelines for informed consent issues
related to sterilization and carrier testing for cystic
fibrosis. [ACOG 2004]
Increased levels of institutional quality (e.g., compliance
with accreditation standards)
Potential time and money savings (or offsets) related
to reduced litigation
Thus, based on guidance
from staff and counsel, each institution generally develops
its own list of surgeries, procedures, or situations where
full informed consent is needed. [Manthous 2003] In fact,
the Joint Commission (formerly known as the Joint Commission
on Accreditation of Healthcare Organizations or JCAHO) has
set a standard that hospitals must establish and follow
policies that describe which procedures or care, treatment,
or services require informed consent. [Joint Commission
2005] One of the first steps recommended in the next
section is to clarify your institution's policies about
when informed consent is required.
Another area subject to local interpretation is exactly
how much to disclose. How many potential risks must be described,
for example, and how many alternatives must be mentioned?
While many states rely on a standard of what a “reasonable
physician” would provide or what a “reasonable
patient” would need, this still leaves room for interpretation.
[ACS 2007, Westcott 2005] Most laws describe the need to
cover all “material” (i.e., significant) risks.
But common sense suggests that not every potential risk
can be described in detail and that only the most prevalent
and/or serious risks and side effects would be covered.
[Wescott 2005] The number and type of complications also
may vary widely depending on the severity of the patient’s
underlying conditions or comorbidities (e.g., pneumothorax
following central vein catheterization may not be life-threatening
in a patient admitted for a soft-tissue abscess but could
be extremely risky in a patient receiving mechanical ventilation
for severe acute respiratory distress syndrome). [Manthous
2003] How can a single form cover both situations? Further
complicating the issue, of course, is the fact that there
are limitations and variations in the capacity of individual
patients to comprehend many of these details—and therefore
the information needs to be tailored for each individual.
It is precisely these gray areas in the requirements for
informed consent—When is it needed? How much is needed?
And how can I make sure the patient understands?—that
have opened the door for many of the documented failures
of informed consent in everyday practice. (See below: “Informed
Consent in Practice” and Appendix A)
One common defensive response to the uncertainties about
how much to disclose, for example, is use of “blanket”
informed consent forms that contain only boiler-plate generalities
that “all potential risks and side effects and alternatives
have been explained and understood by the patient.”
If such a generic consent form is accompanied by genuine
documented education involving appropriate explanation and
printed material, this may work. (Attorneys also usually
advise clinicians to document the details of this interchange
in the patient’s record. [Wescott 2005, AMA 1998])
But on its own, an overly generic consent form without any
significant accompanying education and interchange—that
is, a quick request for a signature while the patient is
on the gurney—is not adequate. On the other hand,
an exhaustive list of all the potential risks may be difficult
for patients to understand. (Attorneys reviewing such a
list would also likely point out that any omission from
such a long and seemingly comprehensive list might be a
red flag, and that such a form would therefore need to state
that the list is not inclusive. [AMA 1998])
[See Appendix A]
Informed Consent in Practice
How often does informed consent work as intended?
How do your practices match up to the national
norms for informed consent?
How does one even begin to measure the “success”
of informed consent?
These are complex questions that have
been tackled by clinicians and researchers from different
settings and perspectives. Many studies have focused
on one therapeutic area of interest. Others have analyzed
the consent process only in the research setting.
And some have evaluated the process in targeted patient
groups such as those with low literacy.
Reviewing the results from such studies provides a
sense of the problems that must still be overcome
in planning for and delivering informed consent in
everyday clinical practice. See Appendix A
for a review of the clinical literature evaluating
what works and what doesn't work in informed consent.
While much of this data comes out of the clinical
research setting, many of the broader “lessons
learned” in these studies are highly applicable
to the setting of everyday informed consent.
Thus, even a brief
review of the requirements for informed consent reveals
the complexity at multiple levels of ethics, law, and effective
medical communications. This guide is meant to help you,
in partnership with your legal staff and clinical team,
navigate these gray areas and, at the end of the day, be
set to provide consistently high-quality informed consent.
A key part of the solution that will be repeated throughout
this publication is that informed consent requires more
than just a good written form—it also requires preparation
for a full discussion with the patient and a check to ensure
that the messages have been received.
Developed with a grant from the Robert Wood Johnson Foundation